VENUS REMEDIES
|
The Current P/E Ratio of VENUS REMEDIES is 13.50.
Share Price | ₹456.7 | Jun 10,2025 |
Market Cap | ₹612.0 Cr | |
Earnings-TTM | ₹45.3 Cr | TTM-Consolidated Results |
Price/Earnings | 13.50x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of VENUS REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹612.0 Cr] as on Jun 10,2025
(/) Earnings [ ₹45.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 13.50x ]
Thus, for VENUS REMEDIES , the investors are currently willing to pay 13.50 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VENUS REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VENUS REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of VENUS REMEDIES
PE Ratio Performance Analysis for VENUS REMEDIES
- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 7.55x.
- VENUS REMEDIES 's operated at median p/e ratio of 8.15x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2024 at 15.31x.
- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0x.
How does VENUS REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
VENUS REMEDIES | 45.33 | 13.50 | 612.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.89 | 405,068.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 80.83 | 177,105.0 |
CIPLA LTD | 5,291.05 | 23.06 | 122,016.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 57.01 | 108,942.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 19.75 | 112,651.0 |
MANKIND PHARMA LTD | 2,003.22 | 48.99 | 98,130.4 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.40 | 98,771.9 |
LUPIN LTD | 3,306.26 | 27.72 | 91,633.7 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.34 | 67,988.6 |
ABBOTT INDIA LTD | 1,414.44 | 47.55 | 67,252.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VENUS REMEDIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 13.50x |
Max industry PE | 80.83x |
Median industry PE | 27.72x |
Average industry PE | 36.00x |
You may also like the below Video Courses